Published in Front Biosci (Schol Ed) on June 01, 2015
Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling. Mol Brain (2016) 0.78
Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank. BMJ Open (2016) 0.75
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs. Pharmaceuticals (Basel) (2016) 0.75
Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining. PLoS One (2016) 0.75
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet (2011) 6.09
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ (2011) 4.37
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ (2006) 3.69
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol (2003) 3.60
Non-European doctors and change in UK policy: ten thousand international medical graduates may be affected. BMJ (2006) 3.54
Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol (2005) 3.31
Ensembl Genomes 2013: scaling up access to genome-wide data. Nucleic Acids Res (2013) 3.08
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci (2010) 2.78
Does social cohesion modify the association between area income deprivation and mental health? A multilevel analysis. Int J Epidemiol (2007) 2.47
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol (2009) 2.10
Orlistat over the counter. BMJ (2007) 2.01
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry (2002) 1.88
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol (2012) 1.86
Sensory stimulation in dementia. BMJ (2002) 1.71
Improving quality of life for people with dementia in care homes: making psychosocial interventions work. Br J Psychiatry (2012) 1.65
Withdrawal of sibutramine in Europe. BMJ (2010) 1.64
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J Pharm Sci (2008) 1.50
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2010) 1.50
Drug repositioning for Alzheimer's disease. Nat Rev Drug Discov (2012) 1.42
A proper place to live: health inequalities, agency and the normative dimensions of space. Soc Sci Med (2003) 1.41
Anti-psychotic drug use in older people. Age Ageing (2002) 1.39
Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr (2010) 1.38
Should medical students be taught alternative medicine? BMJ (2014) 1.37
A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci (2008) 1.30
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry (2010) 1.28
Places, people and mental health: a multilevel analysis of economic inactivity. Soc Sci Med (2006) 1.27
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke (2004) 1.26
Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26
Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr (2009) 1.26
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav (2003) 1.25
The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry (2010) 1.25
Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord (2008) 1.24
Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22
Butyrophilins: an emerging family of immune regulators. Trends Immunol (2011) 1.21
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease. Neurology (2007) 1.16
Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res (2002) 1.16
Beyond 'beer, fags, egg and chips'? Exploring lay understandings of social inequalities in health. Sociol Health Illn (2003) 1.15
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial. PLoS One (2012) 1.14
The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry (2005) 1.13
Autonomic function is impaired in elderly stroke survivors. Stroke (2005) 1.13
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis (2006) 1.12
The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule. J Biol Chem (2006) 1.11
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging (2006) 1.11
Mental health inequalities in Wales, UK: multi-level investigation of the effect of area deprivation. Br J Psychiatry (2005) 1.09
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Comput Biol (2010) 1.07
Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci (2011) 1.04
Altered neurogenesis in Alzheimer's disease. J Psychosom Res (2006) 1.03
Butyrophilin-like 1 encodes an enterocyte protein that selectively regulates functional interactions with T lymphocytes. Proc Natl Acad Sci U S A (2011) 1.01
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry (2004) 1.01
Receptors for myelin inhibitors: Structures and therapeutic opportunities. Mol Cell Neurosci (2009) 1.00
The disconnect between evidence and practice: a systematic review of person-centred interventions and training manuals for care home staff working with people with dementia. Int J Geriatr Psychiatry (2014) 0.99
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci (2012) 0.99
Is physical activity a potential preventive factor for vascular dementia? A systematic review. Aging Ment Health (2010) 0.98
Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis (2012) 0.98
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res (2011) 0.97
Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication. J Biol Chem (2003) 0.97
Public health and primary care: a necessary relationship. Health Soc Care Community (1999) 0.97
Systematic review of services providing information and/or advice to people with dementia and/or their caregivers. Int J Geriatr Psychiatry (2011) 0.97
Developing public sociology through health impact assessment. Sociol Health Illn (2008) 0.96
Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dement Geriatr Cogn Disord (2008) 0.96
Treatment of behavioral and psychological symptoms of Alzheimer's disease. Curr Treat Options Neurol (2012) 0.95
Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features. Int J Geriatr Psychiatry (2010) 0.95
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome. Neurobiol Aging (2013) 0.95
Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia. Dement Geriatr Cogn Disord (2014) 0.94
Fascin regulates the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci (2013) 0.94
The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life. Dement Geriatr Cogn Disord (2006) 0.94
A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care (2003) 0.93
A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue. Clin Sci (Lond) (2003) 0.91
Early and presenting symptoms of dementia with lewy bodies. Dement Geriatr Cogn Disord (2011) 0.91
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenet Genomics (2008) 0.91
Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. Brain (2006) 0.91
Chronic withdrawal of a high-palatable obesity-inducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis (2004) 0.90
The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. Br J Pharmacol (2010) 0.89
Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease. Pharmaceuticals (Basel) (2013) 0.88
Dementia Care Mapping as a research tool for measuring quality of life in care settings: psychometric properties. Int J Geriatr Psychiatry (2002) 0.88
Associations between cognitively stimulating leisure activities, cognitive function and age-related cognitive decline. Int J Geriatr Psychiatry (2014) 0.88
BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Mov Disord (2009) 0.88
Beliefs about common health problems and work: a qualitative study. Soc Sci Med (2008) 0.87
BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett (2009) 0.87
Neurocardiovascular instability in cognitive impairment and dementia. Ann N Y Acad Sci (2002) 0.87
New and emerging treatments for Alzheimer's disease. Expert Opin Emerg Drugs (2012) 0.87
Health inequalities: the need to move beyond bad behaviours. J Epidemiol Community Health (2013) 0.86
Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology (2003) 0.86
Language impairment in dementia: impact on symptoms and care needs in residential homes. Int J Geriatr Psychiatry (2003) 0.86
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dement Geriatr Cogn Disord (2011) 0.86
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials (2009) 0.86
Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dement Geriatr Cogn Disord (2003) 0.86
Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides (2005) 0.86
The molecular basis of the cooperation between EGF, FGF and eCB receptors in the regulation of neural stem cell function. Mol Cell Neurosci (2012) 0.86
Novel attributes of Hed1 affect dynamics and activity of the Rad51 presynaptic filament during meiotic recombination. J Biol Chem (2011) 0.86